Development of sarcoidosis during treatment for chronic hepatitis C with pegylated interferon alfa-2a and ribavirin : case report and literature review

Sarcoidosis is a chronic inflammatory multisystem disease of unknown aetiology. IFN-alfa is an immunomodulatory cytokine, currently used with ribavirin in the treatment of chronic hepatitis C infection. Due to its effects on the immune system, IFN-? may lead to the induction or exacerbation of autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis and sarcoidosis. We report on a 37-year-old man, presenting with sarcoidosis during a six-month course of PEG-IFN alfa-2a and ribavirin for chronic hepatitis C virus genotype 3 infection.

Medienart:

E-Artikel

Erscheinungsjahr:

2013

Erschienen:

2013

Enthalten in:

Zur Gesamtaufnahme - volume:21

Enthalten in:

Le infezioni in medicina - 21(2013), 1 vom: 09. März, Seite 40-44

Sprache:

Italienisch

Weiterer Titel:

Un caso di sarcoidosi associata al trattamento con PEG-IFN α-2a e ribavirina in un paziente affetto da epatite cronica HCV correlata: caso clinico e revisione della letteratura

Beteiligte Personen:

Cacopardo, Bruno [VerfasserIn]
Pinzone, Marilia Rita [VerfasserIn]
Nunnari, Giuseppe [VerfasserIn]

Themen:

3WJQ0SDW1A
49717AWG6K
Antiviral Agents
Case Reports
Glucocorticoids
Interferon-alpha
Journal Article
Peginterferon alfa-2a
Polyethylene Glycols
Prednisone
Q46947FE7K
Recombinant Proteins
Review
Ribavirin
VB0R961HZT

Anmerkungen:

Date Completed 28.01.2014

Date Revised 16.08.2019

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM226090612